nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP1—liver cancer	0.716	1	CbGaD
Alitretinoin—Tretinoin—CRABP1—liver cancer	0.00271	0.673	CrCbGaD
Alitretinoin—Vitamin A—CYP1A1—liver cancer	0.000476	0.118	CrCbGaD
Alitretinoin—Tretinoin—CYP1A1—liver cancer	0.00046	0.114	CrCbGaD
Alitretinoin—Acitretin—ALB—liver cancer	0.000379	0.0943	CrCbGaD
Alitretinoin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000156	0.00121	CcSEcCtD
Alitretinoin—Hypersensitivity—Sorafenib—liver cancer	0.000156	0.00121	CcSEcCtD
Alitretinoin—Renal impairment—Doxorubicin—liver cancer	0.000155	0.0012	CcSEcCtD
Alitretinoin—Dermatitis bullous—Doxorubicin—liver cancer	0.000154	0.0012	CcSEcCtD
Alitretinoin—Face oedema—Epirubicin—liver cancer	0.000154	0.00119	CcSEcCtD
Alitretinoin—Asthenia—Sorafenib—liver cancer	0.000152	0.00118	CcSEcCtD
Alitretinoin—Cardiac arrest—Epirubicin—liver cancer	0.000152	0.00118	CcSEcCtD
Alitretinoin—Cardiac failure—Doxorubicin—liver cancer	0.000151	0.00117	CcSEcCtD
Alitretinoin—Mood swings—Epirubicin—liver cancer	0.000151	0.00117	CcSEcCtD
Alitretinoin—Cerebrovascular accident—Doxorubicin—liver cancer	0.000151	0.00117	CcSEcCtD
Alitretinoin—Lethargy—Doxorubicin—liver cancer	0.000151	0.00117	CcSEcCtD
Alitretinoin—Pruritus—Sorafenib—liver cancer	0.00015	0.00116	CcSEcCtD
Alitretinoin—Blood creatinine increased—Epirubicin—liver cancer	0.000149	0.00116	CcSEcCtD
Alitretinoin—Dehydration—Epirubicin—liver cancer	0.000148	0.00115	CcSEcCtD
Alitretinoin—Osteoarthritis—Doxorubicin—liver cancer	0.000148	0.00114	CcSEcCtD
Alitretinoin—Pain in extremity—Doxorubicin—liver cancer	0.000148	0.00114	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000148	0.00114	CcSEcCtD
Alitretinoin—Dry skin—Epirubicin—liver cancer	0.000146	0.00113	CcSEcCtD
Alitretinoin—Affect lability—Doxorubicin—liver cancer	0.000145	0.00113	CcSEcCtD
Alitretinoin—Diarrhoea—Sorafenib—liver cancer	0.000145	0.00113	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000144	0.00111	CcSEcCtD
Alitretinoin—Nasopharyngitis—Epirubicin—liver cancer	0.000143	0.00111	CcSEcCtD
Alitretinoin—Face oedema—Doxorubicin—liver cancer	0.000142	0.00111	CcSEcCtD
Alitretinoin—Gastritis—Epirubicin—liver cancer	0.000141	0.00109	CcSEcCtD
Alitretinoin—Cardiac arrest—Doxorubicin—liver cancer	0.00014	0.00109	CcSEcCtD
Alitretinoin—Dizziness—Sorafenib—liver cancer	0.00014	0.00109	CcSEcCtD
Alitretinoin—Mood swings—Doxorubicin—liver cancer	0.00014	0.00108	CcSEcCtD
Alitretinoin—Abdominal distension—Epirubicin—liver cancer	0.000139	0.00108	CcSEcCtD
Alitretinoin—Blood creatinine increased—Doxorubicin—liver cancer	0.000138	0.00107	CcSEcCtD
Alitretinoin—Dysphagia—Epirubicin—liver cancer	0.000138	0.00107	CcSEcCtD
Alitretinoin—Asthma—Epirubicin—liver cancer	0.000138	0.00107	CcSEcCtD
Alitretinoin—Dehydration—Doxorubicin—liver cancer	0.000137	0.00106	CcSEcCtD
Alitretinoin—Dry skin—Doxorubicin—liver cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Pancreatitis—Epirubicin—liver cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Vomiting—Sorafenib—liver cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Rash—Sorafenib—liver cancer	0.000134	0.00104	CcSEcCtD
Alitretinoin—Dermatitis—Sorafenib—liver cancer	0.000134	0.00104	CcSEcCtD
Alitretinoin—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000133	0.00103	CcSEcCtD
Alitretinoin—Headache—Sorafenib—liver cancer	0.000133	0.00103	CcSEcCtD
Alitretinoin—Nasopharyngitis—Doxorubicin—liver cancer	0.000132	0.00102	CcSEcCtD
Alitretinoin—Gastritis—Doxorubicin—liver cancer	0.000131	0.00101	CcSEcCtD
Alitretinoin—Dysuria—Epirubicin—liver cancer	0.000129	0.001	CcSEcCtD
Alitretinoin—Neutropenia—Epirubicin—liver cancer	0.000129	0.001	CcSEcCtD
Alitretinoin—Abdominal distension—Doxorubicin—liver cancer	0.000128	0.000996	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Epirubicin—liver cancer	0.000128	0.000994	CcSEcCtD
Alitretinoin—Dysphagia—Doxorubicin—liver cancer	0.000128	0.000989	CcSEcCtD
Alitretinoin—Asthma—Doxorubicin—liver cancer	0.000128	0.000989	CcSEcCtD
Alitretinoin—Pollakiuria—Epirubicin—liver cancer	0.000127	0.000988	CcSEcCtD
Alitretinoin—Nausea—Sorafenib—liver cancer	0.000126	0.000977	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Epirubicin—liver cancer	0.000126	0.000976	CcSEcCtD
Alitretinoin—Weight increased—Epirubicin—liver cancer	0.000125	0.000973	CcSEcCtD
Alitretinoin—Pancreatitis—Doxorubicin—liver cancer	0.000125	0.00097	CcSEcCtD
Alitretinoin—Weight decreased—Epirubicin—liver cancer	0.000125	0.000967	CcSEcCtD
Alitretinoin—Pneumonia—Epirubicin—liver cancer	0.000124	0.000959	CcSEcCtD
Alitretinoin—Infestation NOS—Epirubicin—liver cancer	0.000123	0.000953	CcSEcCtD
Alitretinoin—Drowsiness—Epirubicin—liver cancer	0.000123	0.000953	CcSEcCtD
Alitretinoin—Infestation—Epirubicin—liver cancer	0.000123	0.000953	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000122	0.000945	CcSEcCtD
Alitretinoin—Renal failure—Epirubicin—liver cancer	0.000121	0.000937	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Epirubicin—liver cancer	0.00012	0.000935	CcSEcCtD
Alitretinoin—Stomatitis—Epirubicin—liver cancer	0.00012	0.000929	CcSEcCtD
Alitretinoin—Conjunctivitis—Epirubicin—liver cancer	0.000119	0.000927	CcSEcCtD
Alitretinoin—Urinary tract infection—Epirubicin—liver cancer	0.000119	0.000927	CcSEcCtD
Alitretinoin—Dysuria—Doxorubicin—liver cancer	0.000119	0.000925	CcSEcCtD
Alitretinoin—Neutropenia—Doxorubicin—liver cancer	0.000119	0.000925	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000119	0.00092	CcSEcCtD
Alitretinoin—Sweating—Epirubicin—liver cancer	0.000118	0.000914	CcSEcCtD
Alitretinoin—Pollakiuria—Doxorubicin—liver cancer	0.000118	0.000914	CcSEcCtD
Alitretinoin—Haematuria—Epirubicin—liver cancer	0.000117	0.000909	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Doxorubicin—liver cancer	0.000116	0.000903	CcSEcCtD
Alitretinoin—Weight increased—Doxorubicin—liver cancer	0.000116	0.0009	CcSEcCtD
Alitretinoin—Epistaxis—Epirubicin—liver cancer	0.000116	0.000899	CcSEcCtD
Alitretinoin—Weight decreased—Doxorubicin—liver cancer	0.000115	0.000895	CcSEcCtD
Alitretinoin—Sinusitis—Epirubicin—liver cancer	0.000115	0.000895	CcSEcCtD
Alitretinoin—Agranulocytosis—Epirubicin—liver cancer	0.000115	0.00089	CcSEcCtD
Alitretinoin—Pneumonia—Doxorubicin—liver cancer	0.000114	0.000887	CcSEcCtD
Alitretinoin—Drowsiness—Doxorubicin—liver cancer	0.000114	0.000882	CcSEcCtD
Alitretinoin—Infestation NOS—Doxorubicin—liver cancer	0.000114	0.000882	CcSEcCtD
Alitretinoin—Infestation—Doxorubicin—liver cancer	0.000114	0.000882	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000113	0.000875	CcSEcCtD
Alitretinoin—Renal failure—Doxorubicin—liver cancer	0.000112	0.000867	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Doxorubicin—liver cancer	0.000111	0.000865	CcSEcCtD
Alitretinoin—Haemoglobin—Epirubicin—liver cancer	0.000111	0.00086	CcSEcCtD
Alitretinoin—Stomatitis—Doxorubicin—liver cancer	0.000111	0.00086	CcSEcCtD
Alitretinoin—Urinary tract infection—Doxorubicin—liver cancer	0.000111	0.000858	CcSEcCtD
Alitretinoin—Conjunctivitis—Doxorubicin—liver cancer	0.000111	0.000858	CcSEcCtD
Alitretinoin—Hepatitis—Epirubicin—liver cancer	0.00011	0.000856	CcSEcCtD
Alitretinoin—Haemorrhage—Epirubicin—liver cancer	0.00011	0.000856	CcSEcCtD
Alitretinoin—Hypoaesthesia—Epirubicin—liver cancer	0.00011	0.000852	CcSEcCtD
Alitretinoin—Pharyngitis—Epirubicin—liver cancer	0.00011	0.000849	CcSEcCtD
Alitretinoin—Sweating—Doxorubicin—liver cancer	0.000109	0.000846	CcSEcCtD
Alitretinoin—Urinary tract disorder—Epirubicin—liver cancer	0.000109	0.000845	CcSEcCtD
Alitretinoin—Oedema peripheral—Epirubicin—liver cancer	0.000109	0.000843	CcSEcCtD
Alitretinoin—Haematuria—Doxorubicin—liver cancer	0.000108	0.000841	CcSEcCtD
Alitretinoin—Urethral disorder—Epirubicin—liver cancer	0.000108	0.000839	CcSEcCtD
Alitretinoin—Epistaxis—Doxorubicin—liver cancer	0.000107	0.000832	CcSEcCtD
Alitretinoin—Sinusitis—Doxorubicin—liver cancer	0.000107	0.000828	CcSEcCtD
Alitretinoin—Visual impairment—Epirubicin—liver cancer	0.000106	0.000825	CcSEcCtD
Alitretinoin—Agranulocytosis—Doxorubicin—liver cancer	0.000106	0.000823	CcSEcCtD
Alitretinoin—Erythema multiforme—Epirubicin—liver cancer	0.000104	0.000809	CcSEcCtD
Alitretinoin—Eye disorder—Epirubicin—liver cancer	0.000103	0.0008	CcSEcCtD
Alitretinoin—Tinnitus—Epirubicin—liver cancer	0.000103	0.000798	CcSEcCtD
Alitretinoin—Haemoglobin—Doxorubicin—liver cancer	0.000103	0.000796	CcSEcCtD
Alitretinoin—Flushing—Epirubicin—liver cancer	0.000102	0.000794	CcSEcCtD
Alitretinoin—Haemorrhage—Doxorubicin—liver cancer	0.000102	0.000792	CcSEcCtD
Alitretinoin—Hepatitis—Doxorubicin—liver cancer	0.000102	0.000792	CcSEcCtD
Alitretinoin—Hypoaesthesia—Doxorubicin—liver cancer	0.000102	0.000788	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—liver cancer	0.000101	0.000786	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—liver cancer	0.000101	0.000782	CcSEcCtD
Alitretinoin—Oedema peripheral—Doxorubicin—liver cancer	0.000101	0.00078	CcSEcCtD
Alitretinoin—Angiopathy—Epirubicin—liver cancer	0.0001	0.000777	CcSEcCtD
Alitretinoin—Urethral disorder—Doxorubicin—liver cancer	0.0001	0.000776	CcSEcCtD
Alitretinoin—Chills—Epirubicin—liver cancer	9.9e-05	0.000768	CcSEcCtD
Alitretinoin—Arrhythmia—Epirubicin—liver cancer	9.86e-05	0.000765	CcSEcCtD
Alitretinoin—Visual impairment—Doxorubicin—liver cancer	9.84e-05	0.000763	CcSEcCtD
Alitretinoin—Alopecia—Epirubicin—liver cancer	9.75e-05	0.000756	CcSEcCtD
Alitretinoin—Mental disorder—Epirubicin—liver cancer	9.67e-05	0.00075	CcSEcCtD
Alitretinoin—Erythema multiforme—Doxorubicin—liver cancer	9.65e-05	0.000749	CcSEcCtD
Alitretinoin—Malnutrition—Epirubicin—liver cancer	9.6e-05	0.000745	CcSEcCtD
Alitretinoin—Erythema—Epirubicin—liver cancer	9.6e-05	0.000745	CcSEcCtD
Alitretinoin—Eye disorder—Doxorubicin—liver cancer	9.54e-05	0.00074	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—liver cancer	9.52e-05	0.000738	CcSEcCtD
Alitretinoin—Flushing—Doxorubicin—liver cancer	9.47e-05	0.000735	CcSEcCtD
Alitretinoin—Flatulence—Epirubicin—liver cancer	9.46e-05	0.000734	CcSEcCtD
Alitretinoin—Tension—Epirubicin—liver cancer	9.42e-05	0.000731	CcSEcCtD
Alitretinoin—Nervousness—Epirubicin—liver cancer	9.33e-05	0.000724	CcSEcCtD
Alitretinoin—Back pain—Epirubicin—liver cancer	9.29e-05	0.000721	CcSEcCtD
Alitretinoin—Angiopathy—Doxorubicin—liver cancer	9.26e-05	0.000719	CcSEcCtD
Alitretinoin—Chills—Doxorubicin—liver cancer	9.16e-05	0.000711	CcSEcCtD
Alitretinoin—Arrhythmia—Doxorubicin—liver cancer	9.12e-05	0.000707	CcSEcCtD
Alitretinoin—Vision blurred—Epirubicin—liver cancer	9.05e-05	0.000702	CcSEcCtD
Alitretinoin—Alopecia—Doxorubicin—liver cancer	9.02e-05	0.0007	CcSEcCtD
Alitretinoin—Mental disorder—Doxorubicin—liver cancer	8.94e-05	0.000694	CcSEcCtD
Alitretinoin—Ill-defined disorder—Epirubicin—liver cancer	8.91e-05	0.000691	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—liver cancer	8.89e-05	0.000689	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—liver cancer	8.89e-05	0.000689	CcSEcCtD
Alitretinoin—Anaemia—Epirubicin—liver cancer	8.88e-05	0.000689	CcSEcCtD
Alitretinoin—Agitation—Epirubicin—liver cancer	8.83e-05	0.000685	CcSEcCtD
Alitretinoin—Flatulence—Doxorubicin—liver cancer	8.76e-05	0.000679	CcSEcCtD
Alitretinoin—Tension—Doxorubicin—liver cancer	8.72e-05	0.000677	CcSEcCtD
Alitretinoin—Malaise—Epirubicin—liver cancer	8.66e-05	0.000672	CcSEcCtD
Alitretinoin—Nervousness—Doxorubicin—liver cancer	8.63e-05	0.00067	CcSEcCtD
Alitretinoin—Syncope—Epirubicin—liver cancer	8.61e-05	0.000668	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—liver cancer	8.6e-05	0.000667	CcSEcCtD
Alitretinoin—Palpitations—Epirubicin—liver cancer	8.49e-05	0.000658	CcSEcCtD
Alitretinoin—Loss of consciousness—Epirubicin—liver cancer	8.44e-05	0.000655	CcSEcCtD
Alitretinoin—Cough—Epirubicin—liver cancer	8.38e-05	0.00065	CcSEcCtD
Alitretinoin—Vision blurred—Doxorubicin—liver cancer	8.38e-05	0.00065	CcSEcCtD
Alitretinoin—Convulsion—Epirubicin—liver cancer	8.32e-05	0.000646	CcSEcCtD
Alitretinoin—Hypertension—Epirubicin—liver cancer	8.29e-05	0.000643	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—liver cancer	8.25e-05	0.00064	CcSEcCtD
Alitretinoin—Anaemia—Doxorubicin—liver cancer	8.21e-05	0.000637	CcSEcCtD
Alitretinoin—Chest pain—Epirubicin—liver cancer	8.18e-05	0.000634	CcSEcCtD
Alitretinoin—Myalgia—Epirubicin—liver cancer	8.18e-05	0.000634	CcSEcCtD
Alitretinoin—Arthralgia—Epirubicin—liver cancer	8.18e-05	0.000634	CcSEcCtD
Alitretinoin—Agitation—Doxorubicin—liver cancer	8.17e-05	0.000634	CcSEcCtD
Alitretinoin—Anxiety—Epirubicin—liver cancer	8.15e-05	0.000632	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	8.12e-05	0.00063	CcSEcCtD
Alitretinoin—Discomfort—Epirubicin—liver cancer	8.08e-05	0.000627	CcSEcCtD
Alitretinoin—Malaise—Doxorubicin—liver cancer	8.01e-05	0.000622	CcSEcCtD
Alitretinoin—Dry mouth—Epirubicin—liver cancer	8e-05	0.00062	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—liver cancer	7.97e-05	0.000618	CcSEcCtD
Alitretinoin—Confusional state—Epirubicin—liver cancer	7.9e-05	0.000613	CcSEcCtD
Alitretinoin—Palpitations—Doxorubicin—liver cancer	7.85e-05	0.000609	CcSEcCtD
Alitretinoin—Anaphylactic shock—Epirubicin—liver cancer	7.84e-05	0.000608	CcSEcCtD
Alitretinoin—Oedema—Epirubicin—liver cancer	7.84e-05	0.000608	CcSEcCtD
Alitretinoin—Loss of consciousness—Doxorubicin—liver cancer	7.81e-05	0.000606	CcSEcCtD
Alitretinoin—Infection—Epirubicin—liver cancer	7.79e-05	0.000604	CcSEcCtD
Alitretinoin—Cough—Doxorubicin—liver cancer	7.75e-05	0.000602	CcSEcCtD
Alitretinoin—Shock—Epirubicin—liver cancer	7.71e-05	0.000598	CcSEcCtD
Alitretinoin—Convulsion—Doxorubicin—liver cancer	7.7e-05	0.000597	CcSEcCtD
Alitretinoin—Nervous system disorder—Epirubicin—liver cancer	7.69e-05	0.000596	CcSEcCtD
Alitretinoin—Thrombocytopenia—Epirubicin—liver cancer	7.67e-05	0.000595	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—liver cancer	7.67e-05	0.000595	CcSEcCtD
Alitretinoin—Tachycardia—Epirubicin—liver cancer	7.65e-05	0.000593	CcSEcCtD
Alitretinoin—Skin disorder—Epirubicin—liver cancer	7.61e-05	0.000591	CcSEcCtD
Alitretinoin—Hyperhidrosis—Epirubicin—liver cancer	7.58e-05	0.000588	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—liver cancer	7.57e-05	0.000587	CcSEcCtD
Alitretinoin—Myalgia—Doxorubicin—liver cancer	7.57e-05	0.000587	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—liver cancer	7.57e-05	0.000587	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—liver cancer	7.54e-05	0.000585	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.51e-05	0.000583	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—liver cancer	7.48e-05	0.00058	CcSEcCtD
Alitretinoin—Anorexia—Epirubicin—liver cancer	7.47e-05	0.00058	CcSEcCtD
Alitretinoin—Dry mouth—Doxorubicin—liver cancer	7.4e-05	0.000574	CcSEcCtD
Alitretinoin—Hypotension—Epirubicin—liver cancer	7.32e-05	0.000568	CcSEcCtD
Alitretinoin—Confusional state—Doxorubicin—liver cancer	7.31e-05	0.000567	CcSEcCtD
Alitretinoin—Oedema—Doxorubicin—liver cancer	7.25e-05	0.000563	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—liver cancer	7.25e-05	0.000563	CcSEcCtD
Alitretinoin—Infection—Doxorubicin—liver cancer	7.21e-05	0.000559	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Epirubicin—liver cancer	7.14e-05	0.000554	CcSEcCtD
Alitretinoin—Shock—Doxorubicin—liver cancer	7.14e-05	0.000554	CcSEcCtD
Alitretinoin—Nervous system disorder—Doxorubicin—liver cancer	7.11e-05	0.000552	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—liver cancer	7.1e-05	0.000551	CcSEcCtD
Alitretinoin—Insomnia—Epirubicin—liver cancer	7.09e-05	0.00055	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—liver cancer	7.08e-05	0.000549	CcSEcCtD
Alitretinoin—Skin disorder—Doxorubicin—liver cancer	7.04e-05	0.000547	CcSEcCtD
Alitretinoin—Paraesthesia—Epirubicin—liver cancer	7.04e-05	0.000546	CcSEcCtD
Alitretinoin—Hyperhidrosis—Doxorubicin—liver cancer	7.01e-05	0.000544	CcSEcCtD
Alitretinoin—Dyspnoea—Epirubicin—liver cancer	6.99e-05	0.000542	CcSEcCtD
Alitretinoin—Somnolence—Epirubicin—liver cancer	6.97e-05	0.000541	CcSEcCtD
Alitretinoin—Anorexia—Doxorubicin—liver cancer	6.91e-05	0.000536	CcSEcCtD
Alitretinoin—Dyspepsia—Epirubicin—liver cancer	6.9e-05	0.000535	CcSEcCtD
Alitretinoin—Decreased appetite—Epirubicin—liver cancer	6.81e-05	0.000529	CcSEcCtD
Alitretinoin—Hypotension—Doxorubicin—liver cancer	6.78e-05	0.000526	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Epirubicin—liver cancer	6.77e-05	0.000525	CcSEcCtD
Alitretinoin—Fatigue—Epirubicin—liver cancer	6.76e-05	0.000524	CcSEcCtD
Alitretinoin—Pain—Epirubicin—liver cancer	6.7e-05	0.00052	CcSEcCtD
Alitretinoin—Constipation—Epirubicin—liver cancer	6.7e-05	0.00052	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.61e-05	0.000513	CcSEcCtD
Alitretinoin—Insomnia—Doxorubicin—liver cancer	6.56e-05	0.000509	CcSEcCtD
Alitretinoin—Paraesthesia—Doxorubicin—liver cancer	6.51e-05	0.000505	CcSEcCtD
Alitretinoin—Dyspnoea—Doxorubicin—liver cancer	6.47e-05	0.000502	CcSEcCtD
Alitretinoin—Feeling abnormal—Epirubicin—liver cancer	6.46e-05	0.000501	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—liver cancer	6.45e-05	0.0005	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Epirubicin—liver cancer	6.41e-05	0.000497	CcSEcCtD
Alitretinoin—Dyspepsia—Doxorubicin—liver cancer	6.38e-05	0.000495	CcSEcCtD
Alitretinoin—Decreased appetite—Doxorubicin—liver cancer	6.3e-05	0.000489	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—liver cancer	6.26e-05	0.000486	CcSEcCtD
Alitretinoin—Fatigue—Doxorubicin—liver cancer	6.25e-05	0.000485	CcSEcCtD
Alitretinoin—Urticaria—Epirubicin—liver cancer	6.23e-05	0.000483	CcSEcCtD
Alitretinoin—Pain—Doxorubicin—liver cancer	6.2e-05	0.000481	CcSEcCtD
Alitretinoin—Constipation—Doxorubicin—liver cancer	6.2e-05	0.000481	CcSEcCtD
Alitretinoin—Abdominal pain—Epirubicin—liver cancer	6.2e-05	0.000481	CcSEcCtD
Alitretinoin—Body temperature increased—Epirubicin—liver cancer	6.2e-05	0.000481	CcSEcCtD
Alitretinoin—Feeling abnormal—Doxorubicin—liver cancer	5.98e-05	0.000464	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Doxorubicin—liver cancer	5.93e-05	0.00046	CcSEcCtD
Alitretinoin—Hypersensitivity—Epirubicin—liver cancer	5.78e-05	0.000448	CcSEcCtD
Alitretinoin—Urticaria—Doxorubicin—liver cancer	5.76e-05	0.000447	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—liver cancer	5.73e-05	0.000445	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—liver cancer	5.73e-05	0.000445	CcSEcCtD
Alitretinoin—Asthenia—Epirubicin—liver cancer	5.62e-05	0.000436	CcSEcCtD
Alitretinoin—Pruritus—Epirubicin—liver cancer	5.55e-05	0.00043	CcSEcCtD
Alitretinoin—Diarrhoea—Epirubicin—liver cancer	5.36e-05	0.000416	CcSEcCtD
Alitretinoin—Hypersensitivity—Doxorubicin—liver cancer	5.34e-05	0.000415	CcSEcCtD
Alitretinoin—Asthenia—Doxorubicin—liver cancer	5.2e-05	0.000404	CcSEcCtD
Alitretinoin—Dizziness—Epirubicin—liver cancer	5.18e-05	0.000402	CcSEcCtD
Alitretinoin—Pruritus—Doxorubicin—liver cancer	5.13e-05	0.000398	CcSEcCtD
Alitretinoin—Vomiting—Epirubicin—liver cancer	4.98e-05	0.000387	CcSEcCtD
Alitretinoin—Diarrhoea—Doxorubicin—liver cancer	4.96e-05	0.000385	CcSEcCtD
Alitretinoin—Rash—Epirubicin—liver cancer	4.94e-05	0.000383	CcSEcCtD
Alitretinoin—Dermatitis—Epirubicin—liver cancer	4.94e-05	0.000383	CcSEcCtD
Alitretinoin—Headache—Epirubicin—liver cancer	4.91e-05	0.000381	CcSEcCtD
Alitretinoin—Dizziness—Doxorubicin—liver cancer	4.8e-05	0.000372	CcSEcCtD
Alitretinoin—Nausea—Epirubicin—liver cancer	4.66e-05	0.000361	CcSEcCtD
Alitretinoin—Vomiting—Doxorubicin—liver cancer	4.61e-05	0.000358	CcSEcCtD
Alitretinoin—Rash—Doxorubicin—liver cancer	4.57e-05	0.000355	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—liver cancer	4.57e-05	0.000354	CcSEcCtD
Alitretinoin—Headache—Doxorubicin—liver cancer	4.54e-05	0.000352	CcSEcCtD
Alitretinoin—Nausea—Doxorubicin—liver cancer	4.31e-05	0.000334	CcSEcCtD
Alitretinoin—RARG—Gene Expression—ESR1—liver cancer	2.34e-05	0.000155	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—liver cancer	2.33e-05	0.000154	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	2.31e-05	0.000153	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARA—liver cancer	2.31e-05	0.000153	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—liver cancer	2.31e-05	0.000153	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.28e-05	0.000151	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.27e-05	0.000151	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	2.27e-05	0.00015	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	2.27e-05	0.00015	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	2.27e-05	0.00015	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—liver cancer	2.26e-05	0.00015	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	2.26e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARA—liver cancer	2.26e-05	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTA4—liver cancer	2.26e-05	0.00015	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CD—liver cancer	2.24e-05	0.000148	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CD—liver cancer	2.24e-05	0.000148	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARA—liver cancer	2.22e-05	0.000147	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARA—liver cancer	2.22e-05	0.000147	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—liver cancer	2.21e-05	0.000146	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—liver cancer	2.21e-05	0.000146	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.21e-05	0.000146	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HNF4A—liver cancer	2.2e-05	0.000146	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTA2—liver cancer	2.2e-05	0.000146	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK14—liver cancer	2.18e-05	0.000144	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—ESR1—liver cancer	2.18e-05	0.000144	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—liver cancer	2.17e-05	0.000144	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—liver cancer	2.17e-05	0.000144	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	2.14e-05	0.000142	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ESR1—liver cancer	2.14e-05	0.000142	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK14—liver cancer	2.14e-05	0.000142	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—liver cancer	2.13e-05	0.000141	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTA1—liver cancer	2.12e-05	0.000141	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.12e-05	0.000141	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	2.11e-05	0.00014	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	2.11e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.1e-05	0.00014	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTP1—liver cancer	2.1e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KDR—liver cancer	2.1e-05	0.000139	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NAT2—liver cancer	2.1e-05	0.000139	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	2.1e-05	0.000139	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ESR1—liver cancer	2.1e-05	0.000139	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK14—liver cancer	2.09e-05	0.000138	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	2.08e-05	0.000138	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MET—liver cancer	2.06e-05	0.000136	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK14—liver cancer	2.05e-05	0.000136	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK14—liver cancer	2.05e-05	0.000136	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	2.03e-05	0.000135	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.02e-05	0.000134	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALDOB—liver cancer	2.01e-05	0.000133	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ESR1—liver cancer	2.01e-05	0.000133	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ESR1—liver cancer	2.01e-05	0.000133	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—liver cancer	2e-05	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—liver cancer	1.98e-05	0.000132	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—liver cancer	1.95e-05	0.000129	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CB—liver cancer	1.95e-05	0.000129	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CB—liver cancer	1.95e-05	0.000129	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—liver cancer	1.93e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	1.93e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PSMA4—liver cancer	1.92e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PSMD10—liver cancer	1.92e-05	0.000128	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SERPINE1—liver cancer	1.92e-05	0.000127	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CRABP1—liver cancer	1.92e-05	0.000127	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PPARA—liver cancer	1.92e-05	0.000127	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—liver cancer	1.91e-05	0.000127	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	1.91e-05	0.000126	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.87e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—liver cancer	1.87e-05	0.000124	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	1.87e-05	0.000124	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—liver cancer	1.84e-05	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—CYP1A1—liver cancer	1.83e-05	0.000122	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—liver cancer	1.83e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—liver cancer	1.83e-05	0.000122	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	1.81e-05	0.00012	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	1.8e-05	0.000119	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SERPINE1—liver cancer	1.79e-05	0.000119	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	1.78e-05	0.000118	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	1.78e-05	0.000118	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SERPINE1—liver cancer	1.76e-05	0.000116	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	1.75e-05	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.73e-05	0.000115	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SERPINE1—liver cancer	1.72e-05	0.000114	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—liver cancer	1.72e-05	0.000114	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UGDH—liver cancer	1.72e-05	0.000114	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—liver cancer	1.71e-05	0.000114	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HPGDS—liver cancer	1.68e-05	0.000111	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.67e-05	0.000111	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	1.65e-05	0.00011	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SERPINE1—liver cancer	1.65e-05	0.000109	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SERPINE1—liver cancer	1.65e-05	0.000109	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—EPT1—liver cancer	1.61e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.58e-05	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TAT—liver cancer	1.53e-05	0.000101	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.52e-05	0.000101	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RAF1—liver cancer	1.52e-05	0.000101	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.5e-05	9.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PSMA4—liver cancer	1.5e-05	9.91e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PSMD10—liver cancer	1.5e-05	9.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	1.48e-05	9.79e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT2—liver cancer	1.45e-05	9.64e-05	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—liver cancer	1.43e-05	9.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	1.38e-05	9.12e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UGDH—liver cancer	1.37e-05	9.09e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2E1—liver cancer	1.37e-05	9.07e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.32e-05	8.78e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—liver cancer	1.31e-05	8.72e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—H2AFX—liver cancer	1.3e-05	8.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	1.3e-05	8.61e-05	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—RAF1—liver cancer	1.29e-05	8.55e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—EPT1—liver cancer	1.29e-05	8.55e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—liver cancer	1.29e-05	8.55e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYCS—liver cancer	1.28e-05	8.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGT1—liver cancer	1.26e-05	8.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT1—liver cancer	1.26e-05	8.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TAT—liver cancer	1.22e-05	8.1e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—liver cancer	1.22e-05	8.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	1.2e-05	7.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	1.19e-05	7.89e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—liver cancer	1.19e-05	7.87e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—liver cancer	1.19e-05	7.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	1.17e-05	7.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—liver cancer	1.16e-05	7.67e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARA—liver cancer	1.16e-05	7.66e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—liver cancer	1.15e-05	7.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	1.13e-05	7.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	1.13e-05	7.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—liver cancer	1.13e-05	7.5e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—liver cancer	1.13e-05	7.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	1.12e-05	7.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—liver cancer	1.11e-05	7.38e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—liver cancer	1.11e-05	7.37e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	1.1e-05	7.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	1.09e-05	7.24e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—liver cancer	1.09e-05	7.23e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	1.07e-05	7.1e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK14—liver cancer	1.07e-05	7.08e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—liver cancer	1.06e-05	7.04e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR1—liver cancer	1.05e-05	6.94e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—liver cancer	1.05e-05	6.93e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—liver cancer	1.05e-05	6.93e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CPT1B—liver cancer	1.04e-05	6.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLUL—liver cancer	1.04e-05	6.9e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—liver cancer	1.04e-05	6.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NR1H4—liver cancer	1e-05	6.65e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—liver cancer	9.92e-06	6.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	9.89e-06	6.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA3—liver cancer	9.86e-06	6.54e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—liver cancer	9.84e-06	6.52e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—liver cancer	9.83e-06	6.51e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—liver cancer	9.7e-06	6.43e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—liver cancer	9.7e-06	6.43e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—liver cancer	9.55e-06	6.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	9.49e-06	6.29e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—liver cancer	9.16e-06	6.07e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	9.1e-06	6.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	9.08e-06	6.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA4—liver cancer	9.02e-06	5.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9e-06	5.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARA—liver cancer	8.99e-06	5.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA2—liver cancer	8.79e-06	5.83e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—liver cancer	8.61e-06	5.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA1—liver cancer	8.48e-06	5.62e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	8.48e-06	5.62e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—liver cancer	8.43e-06	5.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	8.41e-06	5.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAT2—liver cancer	8.39e-06	5.56e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—liver cancer	8.36e-06	5.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CPT1B—liver cancer	8.31e-06	5.51e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLUL—liver cancer	8.31e-06	5.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.07e-06	5.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDOB—liver cancer	8.04e-06	5.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NR1H4—liver cancer	8.01e-06	5.31e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—liver cancer	8e-06	5.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA3—liver cancer	7.88e-06	5.22e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	7.73e-06	5.12e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—liver cancer	7.71e-06	5.11e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—liver cancer	7.7e-06	5.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CRABP1—liver cancer	7.67e-06	5.09e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	7.67e-06	5.08e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—liver cancer	7.56e-06	5.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	7.47e-06	4.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—liver cancer	7.43e-06	4.93e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—liver cancer	7.38e-06	4.9e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—liver cancer	7.25e-06	4.81e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—liver cancer	7.25e-06	4.81e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA4—liver cancer	7.2e-06	4.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.04e-06	4.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA2—liver cancer	7.02e-06	4.65e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA1—liver cancer	6.77e-06	4.49e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CD—liver cancer	6.77e-06	4.49e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPGDS—liver cancer	6.71e-06	4.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAT2—liver cancer	6.7e-06	4.44e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—liver cancer	6.68e-06	4.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.44e-06	4.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDOB—liver cancer	6.42e-06	4.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	6.31e-06	4.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CRABP1—liver cancer	6.12e-06	4.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PSMD10—liver cancer	5.98e-06	3.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PSMA4—liver cancer	5.98e-06	3.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CB—liver cancer	5.9e-06	3.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT2—liver cancer	5.81e-06	3.85e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	5.7e-06	3.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.51e-06	3.66e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2E1—liver cancer	5.47e-06	3.62e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—liver cancer	5.45e-06	3.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPGDS—liver cancer	5.35e-06	3.55e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.32e-06	3.53e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	5.15e-06	3.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYCS—liver cancer	5.11e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGT1—liver cancer	5.02e-06	3.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT1—liver cancer	5.02e-06	3.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.85e-06	3.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.79e-06	3.17e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PSMD10—liver cancer	4.77e-06	3.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PSMA4—liver cancer	4.77e-06	3.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT2—liver cancer	4.64e-06	3.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—liver cancer	4.51e-06	2.99e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—liver cancer	4.45e-06	2.95e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2E1—liver cancer	4.36e-06	2.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.23e-06	2.8e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—liver cancer	4.14e-06	2.75e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYCS—liver cancer	4.08e-06	2.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT1—liver cancer	4.01e-06	2.66e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGT1—liver cancer	4.01e-06	2.66e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—liver cancer	3.93e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—liver cancer	3.78e-06	2.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—liver cancer	3.66e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—liver cancer	3.6e-06	2.39e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—liver cancer	3.6e-06	2.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARA—liver cancer	3.59e-06	2.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—liver cancer	3.55e-06	2.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—liver cancer	3.31e-06	2.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—liver cancer	3.14e-06	2.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—liver cancer	3.08e-06	2.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—liver cancer	2.97e-06	1.97e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—liver cancer	2.94e-06	1.95e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—liver cancer	2.92e-06	1.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARA—liver cancer	2.87e-06	1.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CD—liver cancer	2.7e-06	1.79e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—liver cancer	2.67e-06	1.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.58e-06	1.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—liver cancer	2.46e-06	1.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—liver cancer	2.37e-06	1.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CB—liver cancer	2.36e-06	1.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CD—liver cancer	2.16e-06	1.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—liver cancer	2.13e-06	1.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CB—liver cancer	1.88e-06	1.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—liver cancer	1.44e-06	9.53e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—liver cancer	1.17e-06	7.78e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—liver cancer	1.15e-06	7.6e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—liver cancer	9.37e-07	6.21e-06	CbGpPWpGaD
